Yuki Noguchi
Stories
-
After 40 years of smoking, she survived lung cancer thanks to new treatments
Scientific advances in immunotherapy and new targeted therapies have increased survival rates. But screening among former and current smokers still needs to improve to save more lives.
-
Medicare plans can now cover Wegovy for patients at risk of heart disease
This change follows the recent FDA approval of the weight-loss drug for preventing heart attack and stroke in people with overweight or obesity.
-
The fight over banning menthol cigarettes has a long history steeped in race
Black smokers make up menthol tobacco's largest market, and have the highest rates of lung cancer. But the fight over banning menthol is a complex and divisive issue in the Black community.
-
Another Ozempic side effect? Facing the holidays with no appetite
Weight-loss medications tamp down hunger — often dramatically — causing some people to lose the pleasure of communing over food at a festive family meal.
-
Lung cancer survival rates rise, but low screening rates leave many people at risk
A new survey finds more people are surviving lung cancer and racial disparities are shrinking. But unless it's caught early, lung cancer still has a low survival rate.
-
FDA approves Zepbound, a new obesity drug that will take on Wegovy
Eli Lilly said the obesity medicine, which helped adults in clinical studies lose about 20% of their body weight, will be available in the U.S. by the end of the year. The list price will be $1,060.
-
World
Lessons from brain science — and history's peacemakers — for resolving conflicts
Humans instinctually forge loyalties to groups to survive. Being aware of these impulses can help us deescalate arguments and find common ground. Some notable leaders in history show us how it's done.
-
The American Cancer Society says more people should get screened for lung cancer
New guidelines say more current and former smokers should get screened on a yearly basis. New treatments for lung cancer make early detection of the lethal disease more important.
-
The hospital ran out of her child's cancer drug. Now she's fighting to end shortages
Laura Bray couldn't watch her 9-year-old's leukemia go untreated. She started campaigning to fix a broken system and get patients the treatments they need in the face of drug shortages.
-
This year's COVID vaccine rollout is off to a bumpy start, despite high demand
Some people are finding pharmacies still don't have supply of the shots, and others are having insurance coverage troubles. Here's what's going on.